#ProactiveCarePartners, #ProactiveCare, #PrimaryCare, #WholePersonCare, #PreventiveCare, #BenefitsStrategy, #EmployeeBenefits, #EmployeeWellness, #HealthcareStrategy, #HealthBenefits, #HealthBenefitsStrategy, #HealthPlanDesign, #ValueBasedCare, #CorporateWellness, #PopulationHealth, #DataDrivenCare, #PublicHealth, #ChronicDiseaseManagement, #HealthPolicy, #LifestyleMedicine, #HealthcareReform, #GLP1, #PharmacySpend, #ROI GLP-1 RAs and Prior Major Adverse Limb Events in Patients With Diabetes jamanetwork.com To view or add a comment, sign in We call for a shift away from Kt/V-centric quality frameworks and the concept of adequate dialysis, advocating instead for a more holistic model of high-quality, person-centered dialysis care
Cardio Protection of GLP-1 RAs Agonists GLP-1 RAs, including semaglutide and liraglutide, have shown cardiovascular benefits in patients with type 2 diabetes [34], and emerging evidence suggests tirzepatidea dual GLP-1/GIP agonistmay offer even greater cardio protection, including among cancer patients [35]
doi: 10.1186/s12993-025-00273-2 58
Expedited appeal: 72 hours
